Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 320 of 1,261
  1. US 11099172

    In vitro assays for inhibition of microglial activation

    The Regents of the University of California · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  2. US 11098131

    Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies

    Sutro Biopharma, Inc. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  3. US 11098127

    Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  4. US 11098112

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  5. US 11098150

    Block copolymer and micelle compositions and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  6. US 11098103

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Five Prime Therapeutics, Inc. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  7. US 11098082

    Antigenic peptides and uses thereof for diagnosing and treating autism

    The Regents of the University of California · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  8. US 11098101

    Therapeutic compounds and methods

    Regents of the University of Minnesota · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  9. US 11098100

    Therapeutic compounds and methods

    Regents of the University of Minnesota · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  10. US 11098084

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  11. US 11098053

    Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  12. US 11098010

    Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

    ARBUTUS BIOPHARMA CORPORATION · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  13. US 11097034

    Compositions and methods of modulating endochondral ossification and bone formation

    The Regents of the University of California · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  14. US 11098025

    Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

    Montelino Therapeutics Inc. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  15. US 11097035

    Compositions and methods for altering the rate of hydrolysis of cured oil-based materials

    ATRIUM MEDICAL CORPORATION · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  16. US 11097017

    Gadolinium-based contrast agents for sensitive detection of Zn2+with MRI

    The Board of Regents of the University of Texas System · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  17. US 11096997

    Scaffolds for cell transplantation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  18. US 11097011

    Peptide oligonucleotide conjugates

    Sarepta Therapeutics, Inc. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  19. US 11096966

    Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

    RegenLab USA LLC · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  20. US 11096956

    Antisense oligomers and uses thereof

    STOKE THERAPEUTICS, INC. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  21. US 11096965

    Compositions and methods related to polycytotoxic T cells

    The Regents of the University of California · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  22. US 11096946

    Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

    VTV THERAPEUTICS LLC · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  23. US 11096929

    Methods of treating developmental disorders with gaboxadol

    OVID THERAPEUTICS INC. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  24. US 11096900

    Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery

    The Regents of the University of California · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.